EcoDrugPlus

Isotocin Receptor-Like

Ensembl ID : ENSOKIG00005014780
Gene Symbol: LOC109890238
3 Cross references
185 Possible Orthologues:

Kallikrein 1-Related Peptidase B9-Like

Ensembl ID : ENSOKIG00005008021
Gene Symbol: LOC109888624
2 Cross references
988 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOKIG00005024351
Gene Symbol: LOC109865841
3 Cross references
188 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOKIG00005020303
Gene Symbol: LOC109865841
3 Cross references
188 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSOKIG00005015548
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOKIG00005033771
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOKIG00005040418
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOKIG00005028172
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOKIG00005044683
Gene Symbol: KIF5B
3 Cross references
262 Possible Orthologues:

Kinesin-Like Protein Kif11-B

Ensembl ID : ENSOKIG00005046642
Gene Symbol: LOC109890006
3 Cross references
196 Possible Orthologues:

Leukotriene A-4 Hydrolase-Like

Ensembl ID : ENSOKIG00005011319
Gene Symbol: LOC109864355
3 Cross references
199 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSOKIG00005015332
Gene Symbol: LTA4H
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).